abvida-m 50mg/1000mg eazy glide tablet - Uses, Price, Side Effects & Substitutes
What is abvida-m 50mg/1000mg eazy glide tablet used for?
Abvida-M 50mg/500mg Eazy Glide Tablet (Metformin + Vildagliptin) is used to treat ANTI DIABETIC. It contains Metformin (50mg) + Vildagliptin (1000mg), which Metformin decreases hepatic glucose production and increases insulin sensitivity. Always consult your doctor before use. Take as prescribed.
- Generic Name: Metformin + Vildagliptin
- Manufacturer: Abbott
- Form: Allopathy
- Pregnancy Category: C
- Prescription Required: Yes
๐ abvida-m 50mg/1000mg eazy glide tablet Uses & Benefits
Type 2 diabetes mellitus as an adjunct to diet and exercise.
Off-label uses: Polycystic ovary syndrome (Metformin), Gestational diabetes (Metformin)
๐ Drug Information
| Generic Name(s) | Metformin + Vildagliptin |
| Brand Name | Abvida-M 50mg/500mg Eazy Glide Tablet |
| Manufacturer | Abbott |
| Packaging / Form | Varies by brand (Allopathy) |
| Therapeutic Class | ANTI DIABETIC |
| Action Class | ANTI DIABETIC |
| Route of Administration | Oral |
| Storage | Store at room temperature (20-25ยฐC), protect from moisture. |
| Shelf Life | As per manufacturer |
๐ฌ Pharmacology (PK/PD)
Pharmacokinetics
How It Works
Metformin decreases hepatic glucose production and increases insulin sensitivity; Vildagliptin inhibits DPP-4, increasing incretin levels.
Mechanism Steps
๐ก How to Take abvida-m 50mg/1000mg eazy glide tablet
Follow your doctor's prescription exactly.
โ ๏ธ Side Effects of abvida-m 50mg/1000mg eazy glide tablet
โ Common Side Effects
- Nausea
- Diarrhea
- Abdominal pain
- Headache
- Dizziness
- Hypoglycemia
๐จ Serious Side Effects
- Lactic acidosis
- Pancreatitis
- Severe hypoglycemia
- Angioedema
- Hepatic injury
โ ๏ธ Rare Side Effects
- Vitamin B12 deficiency
- Metabolic acidosis
- Skin reactions
- Rhabdomyolysis
Consult your doctor if you experience any unusual symptoms.
๐ฌ Drug Interactions
| โ ๏ธ Drug | Severity | Effect |
|---|---|---|
| Iodinated contrast media | Major | Increased risk of lactic acidosis; discontinue Metformin before procedure. |
| Cimetidine | Major | Reduced renal clearance of Metformin. |
| Topiramate | Major | Increased risk of metabolic acidosis. |
| Corticosteroids | Major | Hyperglycemic effect may reduce efficacy. |
| Diuretics | Major | May cause dehydration and impair renal function. |
| ACE inhibitors | Moderate | Enhanced hypoglycemic effect. |
| Insulin | Moderate | Increased risk of hypoglycemia. |
| Sulfonylureas | Moderate | Increased risk of hypoglycemia. |
| NSAIDs | Moderate | May reduce renal function. |
| Beta-blockers | Moderate | May mask hypoglycemia symptoms. |
| Furosemide | Minor | Possible increase in Metformin concentration. |
| Nifedipine | Minor | Possible increase in Metformin absorption. |
| Digoxin | Minor | Possible increase in digoxin levels. |
| Procainamide | Minor | Competition for renal tubular secretion. |
| Ranitidine | Minor | Possible increase in Metformin levels. |
๐จ Major Interactions
- Contrast media (iodinated)
- Cimetidine
- Topiramate
- Corticosteroids
- Diuretics
โก Moderate Interactions
- ACE inhibitors
- Insulin
- Sulfonylureas
- NSAIDs
- Beta-blockers
โน๏ธ Minor Interactions
- Furosemide
- Nifedipine
- Digoxin
- Procainamide
- Ranitidine
๐ฝ๏ธ Food Interactions
Alcohol, High-fat meals may delay absorption
๐ท Alcohol Interaction
Increased risk of lactic acidosis with Metformin; avoid excessive alcohol.
๐ก๏ธ Safety & Warnings
๐ซ Contraindications
Renal impairment (eGFR <30 mL/min), metabolic acidosis, diabetic ketoacidosis, hypersensitivity, hepatic impairment, acute conditions with risk of hypoxia.
๐ Monitoring Parameters
Blood glucose, HbA1c, renal function (eGFR), liver function, vitamin B12 levels.
๐คฑ Lactation Safety
Not recommended; Metformin is excreted in breast milk; Vildagliptin unknown.
๐ Overdose Management
Supportive care; monitor for lactic acidosis; hemodialysis may remove Metformin.
โฐ Missed Dose
Take as soon as remembered unless near next dose; do not double dose.